At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
D-CEC countingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Search of Circulating Endothelial Cells of Donor Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Evaluation for Potential Clinically Relevant Implications in the Context of Graft-Versus-Host Disease
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia·observational·Posted Jul 31, 2019·Updated Jul 8, 2020
In Brief
An observational study evaluating D-CEC counting for Graft Versus Host Disease, Acute and 2 related conditions. Completed, enrolled 15 participants across 1 site.
Detailed Summary
We believe that CEC, besides coming from cells shedding from patient vasculature, could partly belong to donor, originating from the cellular graft.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
CollaboratorsUniversità degli Studi di Brescia, University of Turin, Italy
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJul 2019
Enrollment StartAug 2019
Primary CompletionJan 2020
Study CompletionApr 2020
TodayJul 2026
First PostedJul 31, 2019
Enrollment StartAug 27, 2019
Primary CompletionJan 31, 2020
Study CompletionApr 30, 2020
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 6.9 years ago
Interventions
D-CEC countingother
By means of preliminary bulk separation step with the CellSearch system, single CEC will be sorted